Clinical Trial

Radiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPC

Name: Radiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPC — clinical trial record (NCT06992232)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This multi-center randomized controlled phase II trial was carried out in several hospitals in China to evaluate the efficacy and safety of radiotherapy or radical prostatectomy combined with intense androgen deprivation therapy for newly diagnosed metastatic prostate cancer.

Trial Details

NCT Number	NCT06992232
Lead Sponsor	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Collaborators: The First Affiliated Hospital of Soochow University, Peking University First Hospital
Conditions	Prostate Cancer Metastatic Disease
Enrollment	144 participants
Start Date	2024-08-01
Primary Completion	2027-07-31 (estimated)
Study Completion	2028-07-31 (estimated)
Updated on ClinicalTrials.gov	2025-05-28